IGC Pharma (IGC) Dividends Paid - Common (2011 - 2012)
IGC Pharma's (IGC) quarterly Dividends Paid - Common came in at $497970.0 in Q4 2012, up 126.02% year-over-year from $220323.2 in Q1 2012, and up 401.98% quarter-over-quarter from -$164901.0 in Q3 2012.
Analysis
IGC Pharma (IGC) Dividends Paid - Common (2011 - 2012) Analysis & Trends
IGC Pharma (IGC) has reported Dividends Paid - Common for 2 consecutive years, with $497970.0 the latest figure, recorded in Q4 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 1.36 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 1.03 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 96.80 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | IGC Pharma | 27.77 Mn | 27.51 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2012 | 497,970.00 |
| Sep 30, 2012 | -164,901.00 |
| Jun 30, 2012 | -540,754.00 |
| Dec 31, 2011 | -1.91 Mn |
| Sep 30, 2011 | -798,215.00 |
| Jun 30, 2011 | -870,954.00 |